Monaco Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
43,966
-27,294
| -38% | -$705K | 0.2% | 45 |
|
|
2025
Q1 | $727K | Sell |
71,260
-64,265
| -47% | -$656K | 0.15% | 49 |
|
|
2024
Q4 | $1.89M | Buy |
135,525
+2,377
| +2% | +$33.2K | 0.27% | 30 |
|
|
2024
Q3 | $2.6M | Sell |
133,148
-11,281
| -8% | -$220K | 0.38% | 32 |
|
|
2024
Q2 | $2.69M | Sell |
144,429
-244,342
| -63% | -$4.54M | 0.43% | 21 |
|
|
2024
Q1 | $5.45M | Sell |
388,771
-9,455
| -2% | -$132K | 1.63% | 13 |
|
|
2023
Q4 | $3.37M | Buy |
398,226
+77,586
| +24% | +$658K | 0.99% | 27 |
|
|
2023
Q3 | $2.86M | Sell |
320,640
-296,741
| -48% | -$2.65M | 0.85% | 19 |
|
|
2023
Q2 | $5.33M | Buy |
+617,381
| New | +$5.33M | 1.49% | 11 |
|
|
2020
Q1 | – | Sell |
-10,333
| Closed | -$3.35M | – | 60 |
|
|
2019
Q4 | $3.35M | Buy |
+10,333
| New | +$3.35M | 1.5% | 10 |
|